This site uses cookies for learning about our traffic, we store no personal details. ACCEPT COOKIES DECLINE COOKIES What are cookies?
univerge site banner
Review Article | Open Access | Eur. J. Med. Health Sci., 5(6), 256-264 | doi: 10.34104/ejmhs.023.02560264

A Review of Antibiotic Resistance: Global Reports, Sources, Incidents, Resistance Strategies, and Control Plans

Mamun Al Asad* Mail Img ,
Zakia Sultana Katha Mail Img ,
Surya Afrin Shorna Mail Img ,
Mohammed Ayaz

Abstract

Antimicrobial resistance is a major global issue that is only getting worse. Acquired resistance is defined by the emergence of coding genes for strategies of drug evasion from antimicrobial agents. The Entero-bacteriaceae family has been linked to this behavior. Antibiotics like beta-lactams and carbapenems, which are the most used types, are used to treat bacterial infections. From a clinical perspective, research on antibiotic resistance is very important because of the effects it has on human health. Furthermore, one of the rare instances of evolution that can be researched in real time is antibiotic resistance. Therefore, doctors, evolutionary biologists, and ecologists are interested in understanding the general processes involved in the acquisition of antibiotic resistance. Environmental microbes are the source of antibiotic resistance genes that are currently found in human diseases. Therefore, research on both natural and medical environments is necessary to fully comprehend the emergence of antibiotic resistance. Recent findings about the evolutionary processes underlying resistance suggest that viability costs, the founder effect, and ecological connectivity are significant barriers that control the spread of resistance from environmental bacteria to diseases. 

INTRODUCTION

Subgroups with a high prevalence of resistance

Travelers returning to nations with modern healthcare systems are frequently the first to the identify "new" antibiotic resistance problems, and screening and the laboratory testing are the strongly advised for people returning after receiving healthcare (Adler et al., 2011; Yong et al., 2009). From very low baselines in those countries, returning Dutch and Swedish international travelers were the reported to have 24% ESBL colo-nization rates. Asymptomatic military personnel sta-tioned in Afghanistan were reported to have 10-fold higher colonization rates of the E. coli that contained ESBL than those stationed in the US (Hasan et al., 2014; Musyok et al., 2019). Antibiotic resistance is also sometimes highly prevalent in the long-term inhabitants of the elderly care institutions, who are frequently exposed to medical care, antibiotics, and common cross-transmission of microorganisms. Hos-pital-linked infections with Staphylococcus aureus, the Staphylococcus epidermis, Stenotrophomonas malto-philia, Streptococcus pneumoniae, Acinetobacter bau-mannii, Burkholderia cepacia, Campylobacter jejuni, Citrobacter freundii, Clostridium difficile, Entero-bacter spp., Enterococcus faecium, Enterococcus fae-calis, E. coli, Haemophilus influenzae, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeru-ginosa, Salmonella spp., and Serratia spp., are the available antibiotic resistance data, in which antibiotic exposure and cross-transmission are expected to be increased (Davies & Davies, 2010; Musyok et al., 2019).

Antibiotic resistance in isolates from environmental and agricultural sources

Resistance is likely influenced by antimicrobials used in animal husbandry as well as trash and effluent from manufacturers and hospitals (Diwan et al., 2010).  Human and animal waste contaminates the environ-ment, and in both resource-poor and resource-rich nations, highly resistant E. coli may be present in the drinking and environmental water supplies. Similar multi-resistant isolations to humans may be found in domestic pets. Antibiotic-resistant human infections are also frequently found in food and in animals that are part of the food chain (Schmiedel et al., 2014; Timofte et al., 2011). Animals in the wild are the frequently impacted, especially scavengers like sea-gulls, who are significant carriers of the antibiotic resistance in the infections known to affect humans (Iredell et al., 2016).

Bacterial resistance strategies against antibiotics

Antibiotic-resistant bacteria are a serious and the expanding global issue. Antibiotic-resistant bacteria have evolved a variety of defense mechanisms, making illness treatment difficult. These resistance mecha-nisms might be acquired (formed over time because of selective pressure from antibiotic use) or intrinsic (occurring naturally). A list of antibiotics and their modes of action are given in Table 2.

Table 2: Names of drugs and their resistance mechanisms (Davies & Davies, 2010; Morar & Wright, 2010). 

Antibiotic management plans 

Antibiotic stewardship programs, also known as anti-biotic management plans, are comprehensive initia-tives used in hospital settings to guarantee the prudent use of antibiotics. These strategies seek to minimize the emergence of antibiotic resistance, enhance patient outcomes, and maximize the use of antibiotics. Global antibiotic resistance control is a long-term endeavor requiring tenacity & cooperation from nations, institu-tions, healthcare systems, and the public. We can stop the development of antibiotic resistance and ensure that antibiotics remain effective for the upcoming generations by cooperating and putting these methods into practice. Here are some key strategies for the antibiotic resistance management:

Antibiotic stewardship 

This entails using antibiotics sensibly and only pres-cribing them when essential. Medical practitioners should refrain from giving antibiotics for viral infec-tions and instead choose the appropriate drug, dosage, and course of therapy.

Public awareness and education 

It is crucial to raise public awareness of the risks associated with antibiotic resistance. Its critical that people comprehend the significance of taking anti-biotics exactly as the directed, refraining from sharing medications, and not forcing physicians to prescribe drugs when none are necessary.

Surveillance and monitoring 

Its important to regularly monitor patterns of antibiotic resistance. This information can direct public health initiatives and assist medical professionals in making well-informed judgments regarding which antibiotics to prescribe diseases.

Infection prevention and control

Appropriate controls for infections in healthcare envi-ronments can help stop the spread of microorganisms resistant to antibiotics. This covers precautions like hand washing, isolating patients who have infec-tions that are resistant, and following sanitation guidelines.

Research and development 

To counteract the emergence of resistance, it is critical to develop novel antibiotics and complementary thera-pies. It is essential to the fund research into novel antibiotics and treatments.

Vaccination 

Antibiotic use can be decreased using vaccines, which can help avoid numerous bacterial infections. In this sense, vaccinations against certain forms of meningitis and bacterial pneumonia, for example, have proven helpful.

One health approach 

It is essential to understand how the health of people, animals, and the environment are interconnected. For instance, the use of antibiotics in agriculture may enco-urage the growth of resistant bacteria that may harm people. In a "One Health" strategy, the human and animal health sectors work together to manage anti-biotic resistance holistically.

Regulatory measures 

Governments have the power to control the use of antibiotics in both agriculture and healthcare. One way to reduce resistance is to implement and enforce laws and regulations that limit the improper use of anti-biotics.

Development of fast diagnostic tests 

Accurate antibiotic prescriptions can be made by the health-care professionals with the aid of enhanced diagnostic tests that can rapidly determine the kind of infection and the bacterium causing it.

International cooperation 

Since antibiotic resistance is a worldwide issue, coope-ration between nations is the crucial. Nations can cooperate on research and policy development, as well as exchange information and best practices.

Alternative therapies 

One viable way to the fight antibiotic resistance is to investigate and develop non-antibiotic medicines like phage therapy, antibodies, and other cutting-edge tech-niques.

Patient engagement

One way to stop the overuse of antibiotics is to encour-age patients to take an active role in their care. This entails talking about available treatment alternatives, posing inquiries, and realizing how crucial it is to adhere to recommended treatment plans.

CONCLUSION

Antibiotic resistance is a global health crisis that the develops when bacteria develop the ability to survive and multiply in the presence of the antibiotics. This resistance might make treating bacterial infections more difficult, which might lead to infections that are more serious and the require longer recovery times. Antibiotic resistance must be controlled if antibiotics are to be effective in the future as well as the present. To effectively control antibiotic resistance, a multidisc-ciplinary strategy involving the medical professionals, rese-archers, legislators, and the public is needed. To counter this growing threat to the public health, cooperation is essential.

ACKNOWLEDGEMENT

We regret failing to properly credit the authors for numerous important works in the subject. Over the 200,000 publications have been made regarding resistance to antibiotics since the 1950s, so while our selection was selective, it was not meant to be all-inclusive. We would like to the extend our sincere gratitude to our family, our supervisor and the co-supervisor, for helping me to prepare the manuscript.

CONFLICTS OF INTERESTS

The authors declare no conflict of interest

Article References:

  1. Abraham, E. P., & Chain, E. (1940). An enzyme from bacteria able to destroy penicillin. Nature, 146(3713), 837-837. https://www.nature.com/articles/146837a0 
  2. Adler, A., Shklyar, M., and Schwaber, M. J., (2011). Introduction of OXA-48-producing Ente-robac-teriaceae to Israeli hospitals by medical tourism. Journal of Antimicrobial Chemotherapy, 66(12), 2763-2766. 
  3. Ahmed, I., Rabbi, M. B., & Sultana, S. (2019). Antibiotic resistance in Bangladesh: A systematic review. Inter J. of Infectious Diseases, 80, 54-61. https://www.sciencedirect.com/science/article/pii/S1201971219300086 
  4. Beutler, J. A. (2009). Natural products as a foun-dation for drug discovery. Current protocols in pharmacology, 46(1), 9.11. 11-19.11. 21. 
  5. Brenner, D. J., Krieg, N. R., & Garrity, G. (2005). Bergeys Manual® of Systematic Bacteriology, 2, The Proteobacteria (Part C): Springer.
  6. Brötz-Oesterhelt, H., & Brunner, N. A. (2008). How many modes of action should an antibiotic have? Current opinion in pharm., 8(5), 564-573. 
  7. DCosta, V. M., McGrann, K. M., & Wright, G. D. (2006). Sampling the antibiotic resistome. Sci-ence, 311(5759), 374-377. https://doi.org/10.1126/science.1120800  
  8. Davies, J. (1995). Vicious circles: looking back on resistance plasmids. Genetics, 139(4), 1465. 
  9. Davies, J., & Davies, D. (2010). Origins and evo-lution of antibiotic resistance. Microbiology and molecular biology reviews, 74(3), 417-433. 
  10. Diwan, V., Tamhankar, A. J., and Stålsby-Lund-borg, C. (2010). Antibiotics and antibiotic-resis-tant bacteria in waters associated with a hospital in Ujjain, India. BMC public health, 10(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/20626873/ 
  11. Dodds, D. R. (2017). Antibiotic resistance: A cur-rent epilogue. Biochemical pharmacology, 134, 139-146. 
  12. Durand, G. A., Raoult, D., & Dubourg, G. (2019). Antibiotic discovery: history, methods and perspectives. Inter  j. of antimicrobial agents, 53 (4), 371-382. 
  13. Gillespie, S. H. (2002). Evolution of drug resis-tance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrobial agents and chemotherapy, 46(2), 267-274. 
  14. Hasan, B., Olsen, B., & Zahra, R. (2014). Emer-gence of carbapenem-resistant Acinetobacter bau-mannii in hospitals in Pakistan. J. of medical microbiology, 63(1), 50-55.  https://pubmed.ncbi.nlm.nih.gov/24085817/ 
  15. Helinski, D. R. (2004). Introduction to plasmids: a selective view of their history. Plasmid biology, 1-21. 
  16. Iredell, J., Brown, J., and Tagg, K. (2016). Antibiotic resistance in Enterobacteriaceae: mec-hanisms and clinical implications. Bmj, 352. https://doi.org/10.1136/bmj.h6420 
  17. Lazm, A. M., Al-Dahmoshi, H. O., & Al-Khafaji, NS. (2019). Antibiotics resistance patterns among Enterobacteriaceae isolated from different clinical samples. Drug Invention Today, 12(05), 938-942. 
  18. Levy, S. B., & Marshall, B. (2004). Antibacterial resistance worldwide: causes, challenges and res-ponses. Nat. medicine, 10(Suppl 12), S122-S129. 
  19. Llor, C., & Bjerrum, L. (2014). Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic advances in drug safety, 5(6), 229-241. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232501/ 
  20. Mader, R., Damborg, P., & Fitzgerald, W. (2021). Building the European antimicrobial resistance surveillance network in the veterinary medicine (EARS-Vet). Eurosurveillance, 26(4), 2001359. 
  21. Momtaz, H., Rezvani, A., & Yarali, S. (2012). Shiga toxin-producing Escherichia coli isolated from bovine mastitic milk: serogroups, virulence factors, and antibiotic resistance properties. The Scientific World J., 2012. 
  22. Morar, M., & Wright, G. D. (2010). The genomic enzymology of antibiotic resistance. Annu Rev Genet, 44, 25-51. https://doi.org/10.1146/annurev-genet-102209-163517 
  23. Musyok, V. M., Masik, M. M., and Muthin, F. (2019). Antimicrobial susceptibility pattern of Acinetobacter isolates from patients in Kenyatta National Hospital, Nairobi, Kenya. Pan African Medical J., 33(1). 
  24. Organizatioournaln, W. H. (2014). Antimicrobial resistance: global report on surveillance: World Health Organization.
  25. Organization, W. H. (2020). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. 
  26. Paterson, D. L., and Bonomo, R. A. (2005). Ex-tended-spectrum β-lactamases: a clinical update. Clinical microbiology reviews, 18(4), 657-686. 
  27. Pitout, J., Revathi, G., and Poirel, L. (2008). Me-tallo-β-lactamase-producing Pseudomonas aeru-ginosa isolated from a large tertiary centre in Kenya. Clinical Microbiology & Infection, 14(8), 755-759. https://doi.org/10.1111/j.1469-0691.2008.02030.x 
  28. Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015). Antimicrobial resistance: a global multifaceted phenomenon. Pathogens & global health, 109(7), 309-318. 
  29. Rahman MA, Mahmud S, Uddin ME, and Ahmed R. (2019). Isolation, identification, and antibiotic sensitivity pattern of Salmonella spp from locally isolated egg samples. Am. J. Pure Appl. Sci., 1(1), 1-11. https://doi.org/10.34104/ajpab.019.019111 
  30. Schmiedel, J., Falgenhauer, L., & Chakraborty, T. (2014). Multiresistant extended-spectrum β-lacta-mase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC microbiology, 14(1), 1-13. 
  31. Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013). The multifaceted roles of antibiotics and antibiotic resistance in nature. Frontiers in microbiology, 4, 47. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594987/ 
  32. Serwecińska, L. (2020). Antimicrobials & anti-biotic-resistant bacteria: a risk to the environment and to public health. Water, 12(12), 3313. 
  33. Shahen MZ, Mahmud S, Islam MM, Uddin ME and Alam MS. (2019). Effect of antibiotic sus-ceptibility and inhibitory activity for the control of growth and survival of microorganisms of extracts of C. officinalis. Eur. J. Med. Health Sci., 1(3), 1-9. https://doi.org/10.34104/ejmhs.0190109  
  34. Spellberg, B., & Gilbert, D. N. (2014). The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clinical infectious diseases, 59(suppl_2), S71-S75. 
  35. Strohl, W. R. (1997). Biotechnology of anti-biotics. (No Title). 
  36. Szekeres, E., Baricz, A., & Dragos, N. (2017). Abundance of antibiotics, antibiotic resistance genes and bacterial community composition in wastewater effluents from different Romanian hospitals. Environmental Pollution, 225, 304-315. 
  37. Tacconelli, E. (2017). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development. 
  38. Tao, S., Li, N., & Liang, W. (2022). The spread of antibiotic resistance genes in vivo model. Cana-dian J. of Infectious Diseases and Medical Micro-biology, 2022. 
  39. Timofte, D., Fick, J., & Williams, N. J. (2011). Detection of the extended-spectrum-β-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis. Journal of Clinical Microbiology, 49(9), 3411-3414. https://doi.org/10.1128/JCM.01045-11 
  40. Uddin, T. M., Chakraborty, A. J., & Sahibzada, M. U. K. (2021). Antibiotic resistance in micro-bes: History, mechanisms, therapeutic strategies and future prospects. J. of infection and public health, 14(12), 1750-1766. 
  41. Ventola C. (2015). The antibiotic resistance crisis: part 1: causes and threats. PT A peer-reviewed J Formul Manag, 40, 277–283.
  42. Watkins, R. R., & Bonomo, R. A. (2016). Over-view: global & local impact of antibiotic resis-tance. Infectious Disease Clinics, 30(2), 313-322. 
  43. Yong, D., Toleman, M. A., Lee, K., & Walsh, T. R. (2009). Characterization of a new metallo-β-lacta-mase gene, bla NDM-1, and a novel ery-thromycin esterase gene carried on a unique gene-tic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial agents and che-motherapy, 53(12), 5046-5054. 
  44. Zaman, S. B., Mamun, K. T., & Hossain, N. (2017). A review on antibiotic resistance: alarm bells are ringing. Cureus, 9(6). https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=92161  

Article Info:

Academic Editor 

Md. Ekhlas Uddin Dipu, Department of Biochemistry and Molecular Biology Gono Bishwabidalay, Dhaka, Bangladesh.

Received

November 14, 2023

Accepted

December 21, 2023

Published

December 27, 2023

Article DOI: 10.34104/ejmhs.023.02560264

Corresponding author

Mamun Al Asad*

PhD Researcher, Department of Microbiology, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh.

Cite this article

Asad MA, Katha ZS, Shorna SY, and Ayaz M. (2023). A review of antibiotic resistance: global reports, sources, incidents, resistance strategies, and control plans, Eur. J. Med. Health Sci., 5(6), 256-264. https://doi.org/10.34104/ejmhs.023.02560264  

Views
280
Download
124
Citations
Badge Img
Share